← Back to Search

Meal Replacements for Weight Loss and Diabetes

N/A
Waitlist Available
Led By Dr Dylan MacKay, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Female participant who is pregnant, lactating or planning pregnancy during the course of the program
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at enrollment (week 0) and end of study (week 16)
Awards & highlights

Summary

This trial aims to see if using WI meal replacements in the Wellness Institute's Weight Loss Clinic program is feasible and helps with weight loss. They will compare the weight loss clinic program with and without the meal

Who is the study for?
This trial is for individuals with obesity, diabetes, or prediabetes who are interested in weight loss and diabetes remission. Participants should be willing to follow the Wellness Institute's Weight Loss Clinic program for 16 weeks and log their meal replacement consumption.
What is being tested?
The study tests if adding plant-based meal replacements (bars or shakes) to a weight loss clinic program can help with weight loss and improve lifestyle behaviors compared to the same program without these products. It also looks at whether it helps in reversing diabetes.
What are the potential side effects?
Since this trial involves food products designed as meal replacements, side effects may include digestive changes depending on individual tolerance to plant-based ingredients.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not pregnant, breastfeeding, nor planning to become pregnant during the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at enrollment (week 0) and end of study (week 16)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at enrollment (week 0) and end of study (week 16) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility of incorporating the WI meal replacements into their weight loss clinic design.
Secondary study objectives
Cardiovascular Assessment
Changes in BMI
Changes in Body Weight
+4 more
Other study objectives
Change in Physical Activity Behaviour Patterns
Changes in Diastolic Blood Pressure
Changes in Dietary Intake - Available Carbohydrates
+17 more

Trial Design

2Treatment groups
Active Control
Group I: The WLC program plus meal replacementsActive Control1 Intervention
Participants will have a choice on what type of meal replacement they will consume each day (either a bar or a shake) and will record this in the product consumption log.
Group II: The WLC program onlyActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
615 Previous Clinical Trials
206,627 Total Patients Enrolled
Sustainable Canadian Agricultural PartnershipUNKNOWN
Seven Oaks Hospital Chronic Disease Innovation CentreNETWORK
3 Previous Clinical Trials
174 Total Patients Enrolled
~27 spots leftby Mar 2026